Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.

OBJECTIVE To evaluate whether enlarged substantia nigra hyperechogenicity (SN+) is associated with an increased risk for Parkinson disease (PD) in a healthy elderly population. DESIGN Longitudinal 3-center observational study with 37 months of prospective follow-up. SETTING Individuals 50 years or older without evidence of PD or any other neurodegenerative disease. PARTICIPANTS Of 1847 participants who underwent a full medical history, neurological assessment, and transcranial sonography at baseline, 1535 could undergo reassessment. MAIN OUTCOME MEASURE Incidence of new-onset PD in relation to baseline transcranial sonography status. RESULTS There were 11 cases of incident PD during the follow-up period. In participants with SN+ at baseline, the relative risk for incident PD was 17.37 (95% confidence interval, 3.71-81.34) times higher compared with normoechogenic participants. CONCLUSIONS In this prospective study, we demonstrate for the first time a highly increased risk for PD in elderly individuals with SN+. Transcranial sonography of the midbrain may therefore be a promising primary screening procedure to define a risk population for imminent PD.

[1]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[2]  G Becker,et al.  Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.

[3]  J. Benito-León,et al.  Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[5]  U. Dillmann,et al.  Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population , 2011, Neurobiology of Aging.

[6]  G Becker,et al.  Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.

[7]  D. Morens,et al.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.

[8]  L. Schöls,et al.  Transcranial sonography in spinocerebellar ataxia type 3. , 2004, Journal of neural transmission. Supplementum.

[9]  Daniela Berg,et al.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. , 2002, Archives of neurology.

[10]  K. Marder,et al.  Risk of Parkinson's disease among first-degree relatives , 1996, Neurology.

[11]  John Hardy,et al.  Parkinson's disease , 2009, The Lancet.

[12]  Matthias Reimold,et al.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study , 2008, The Lancet Neurology.

[13]  G Becker,et al.  Iron accumulation in the substantia nigra in rats visualized by ultrasound. , 1999, Ultrasound in medicine & biology.

[14]  Andrew Siderowf,et al.  Parkinson's at risk syndrome: Can Parkinson's disease be predicted? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  A. Siderowf,et al.  Premotor Parkinson's disease: Clinical features and detection strategies , 2009, Movement disorders : official journal of the Movement Disorder Society.

[16]  Uwe Walter,et al.  Transcranial sonography in movement disorders , 2008, The Lancet Neurology.

[17]  H. Berendse,et al.  Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[18]  M Richards,et al.  Subtle extrapyramidal signs can predict the development of dementia in elderly individuals , 1993, Neurology.

[19]  W. Poewe.  The need for neuroprotective therapies in Parkinson’s disease , 2006, Neurology.

[20]  C. Tanner,et al.  Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.

[21]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[22]  Uwe Walter,et al.  Transcranial brain parenchyma sonography in movement disorders: state of the art. , 2007, Ultrasound in medicine & biology.

[23]  Uwe Walter,et al.  Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. , 2007, Archives of neurology.

[24]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[25]  D. Dressler,et al.  Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy , 2004, Neurology.

[26]  E. Wolters,et al.  Recognition and management of Parkinson’s disease during the premotor (prodromal) phase , 2009, Expert review of neurotherapeutics.

[27]  R. Mayeux,et al.  Parkinsonian signs in older people , 2003, Neurology.

[28]  U. Dillmann,et al.  Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly , 2010, Movement disorders : official journal of the Movement Disorder Society.

[29]  C. van Weel,et al.  Symptoms and duration of the prodromal phase in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[30]  D. Dressler,et al.  Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia , 2006, Journal of Neurology.